Nuseed’s GMO canola set to become world’s first plant-based source of long-chain omega-3 fatty acids

canolaaa

Australian and New Zealand regulators have given the green light to Nuseed’s omega-3 canola variety for and use in animal, fish and human foods, signalling a market breakthrough for parent company, Nufarm.

One hectare [2.5 acres] of the new omega-3 canola has the potential to provide the same omega-3 oil yield as 10,000 kilograms [22,046 pounds] of wild-caught fish, according to Nuseed.

The genetically modified canola variety is the world’s first plant-based source of long-chain omega-3 fatty acids, most commonly found in seafood in healthy proportions.

The omega-3 project is opening big North American and Asian market opportunities given that long-chain omega-3 DHA and EPA are essential for human and fish health.

The company plans to initially commercialise its omega-3 oil – branded as Aquaterra – for aquaculture feed uses, followed by Nutriterra for human nutrition applications.

Developed in collaboration with the CSIRO and the Grains Research and Development Corporation (GRDC), the omega-3 oilseed canola has been approved by the Australian Office of Gene Technology Regulator.

Food uses of the omega-3 canola have been reviewed by Food Standards Australia-New Zealand, with approval granted for sale and use in food in both countries.

This new proprietary product aims to help relieve pressure on wild fish stocks, the current source for this important nutrient.

Read full, original post: Approval for Nuseed’s omega-3 canola

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot 2026-10-16 at 5.38
PFAS in Agriculture: Science, Uncertainty, and Risk Communication
Discarded Green Cap on Public Trash Can
'Blatant slap in the face': MAHA activists turn on RFK Jr. and Trump administration
newborn baby spit up gerd
Vaccine-preventable congenital infections are a leading driver of autism
Screenshot 2026-10-16 at 11.17
Viewpoint: Latest attack on renewable energy and farmers, new USDA rules could put solar grants out of reach for small producers
Government Briefing on Autism Trends
Viewpoint: ‘Statistical murder’: Kennedy’s expanding record of “duplicity and mendacity”
FDA Vials and Syringes Flat Lay
Online gold rush of unapproved peptides is outrunning federal regulators
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-10-14-at-11.45.36-AM
Viewpoint: RFK Jr.’s stacked FDA advisory council endorses multicancer screening test from ethically- questionable company that would increase false positives and waste billions of dollars
Screenshot-2026-10-15-at-9.51.15-AM
 Viewpoint: Selective pronatalism: The radical “ethical” case challenging parents’ right to end a pregnancy when a fetus has a severe genetic disorder
Screenshot-2026-10-15-at-12.13.33-PM
Ahead of the midterms, Meta has paid at least 29 anti-LGBTQ accounts for their posts
Screenshot-2026-10-12-at-10.44.38-AM
Widely condemned as unethical, hepatitis B vaccine study funded by RFK Jr’s CDC gets a final greenlight
Prescription Capsules Scattered on Twenty-Dollar Bills
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it, Part 2
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.